CN112870144A - Oral care product for resisting helicobacter pylori - Google Patents
Oral care product for resisting helicobacter pylori Download PDFInfo
- Publication number
- CN112870144A CN112870144A CN202110102308.7A CN202110102308A CN112870144A CN 112870144 A CN112870144 A CN 112870144A CN 202110102308 A CN202110102308 A CN 202110102308A CN 112870144 A CN112870144 A CN 112870144A
- Authority
- CN
- China
- Prior art keywords
- extract
- helicobacter pylori
- oral care
- menthol
- care product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 14
- 241000590002 Helicobacter pylori Species 0.000 title description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 17
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940041616 menthol Drugs 0.000 claims abstract description 17
- 241000755540 Indocalamus Species 0.000 claims abstract description 13
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 13
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 13
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960003500 triclosan Drugs 0.000 claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims abstract description 12
- 241000334160 Isatis Species 0.000 claims abstract description 12
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 12
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 12
- 102000016943 Muramidase Human genes 0.000 claims abstract description 12
- 108010014251 Muramidase Proteins 0.000 claims abstract description 12
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 12
- 241000241413 Propolis Species 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 claims abstract description 12
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 12
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 12
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 12
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 12
- 229960000274 lysozyme Drugs 0.000 claims abstract description 12
- 239000004325 lysozyme Substances 0.000 claims abstract description 12
- 229920001184 polypeptide Polymers 0.000 claims abstract description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 12
- 229940069949 propolis Drugs 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229960004029 silicic acid Drugs 0.000 claims abstract description 12
- 239000000600 sorbitol Substances 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 244000118350 Andrographis paniculata Species 0.000 claims abstract description 11
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 11
- 241001313857 Bletilla striata Species 0.000 claims abstract description 10
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 3
- 235000011477 liquorice Nutrition 0.000 claims abstract description 3
- 239000008213 purified water Substances 0.000 claims abstract description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 244000212319 Alnus nepalensis Species 0.000 claims description 9
- 229940069445 licorice extract Drugs 0.000 claims description 9
- 241000555712 Forsythia Species 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 241000746375 Andrographis Species 0.000 claims description 2
- 241001313855 Bletilla Species 0.000 claims description 2
- 241001523681 Dendrobium Species 0.000 claims description 2
- 235000020230 cinnamon extract Nutrition 0.000 claims description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 2
- 210000000214 mouth Anatomy 0.000 abstract description 11
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 230000002924 anti-infective effect Effects 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000003181 biological factor Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- -1 antiproliferative Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-helicobacter pylori oral care product, which comprises the following raw materials: triclosan, herbal essence, scutellaria baicalensis, sophora flavescens, andrographis paniculata, vitamin C, lactoferrin, biological lysozyme, a nipaler cinnamomum cassia extract, indocalamus leaves, a liquorice extract, an isatis root extract, a forsythia suspensa extract, sorbitol, hydrated silica, plant polypeptide, propolis, menthol, a honeysuckle extract, glycerol, a bletilla striata extract, a dendrobium officinale extract, sodium lauryl sulfate and the balance of purified water; the invention can clean the oral cavity, whiten the teeth, freshen breath, effectively inhibit the bacterial breeding in the oral cavity and has the functions of antibiosis and anti-infection.
Description
Technical Field
The invention relates to toothpaste, in particular to an anti-helicobacter pylori oral care product.
Background
Oral infection generally refers to inflammation caused by bacterial invasion in the oral cavity, and the most common inflammation in the oral cavity is pulpitis or periapical inflammation, and also infections in the gaps between the oral and maxillofacial regions.
Oral and maxillofacial infection is a common disease in stomatology. The oral cavity, jaw and face infection has the commonality of red, swollen, hot, painful and dysfunctional infection, and the occurrence, development and prognosis of the infection have the particularity due to the anatomical and physiological characteristics of the oral cavity, jaw and face. Infection refers to a disease in which various biological factors propagate and invade in a host body, and under the interaction between the biological factors and the host body, the body generates a series of systemic and local tissue reactions mainly based on defense.
In the prior art, most toothpaste has no antibacterial and anti-infection functions.
Disclosure of Invention
The invention aims to overcome the defects and shortcomings of the prior art and provide an anti-helicobacter pylori oral care product.
In order to achieve the purpose, the invention adopts the technical scheme that: the composite material comprises the following raw materials in parts by weight: 0.05-0.3% of triclosan, 1-2% of herbal essence, 0.5-1% of scutellaria baicalensis, 0.05-0.1% of radix sophorae flavescentis, 0.02-0.05% of common andrographis herb, 2-3% of vitamin C, 2-5% of lactoferrin, 10-15% of biological lysozyme, 2-3% of Nipagin cinnamon extract, 1-2% of indocalamus leaf, 4-6% of liquorice extract, 2-4% of isatis root extract, 1-2% of fructus forsythiae extract, 3-8% of sorbitol, 30-35% of hydrated silica, 4-7% of plant polypeptide, 0.2-0.6% of propolis, 2-4% of menthol, 0.5-1% of honeysuckle extract, 8-10% of glycerol, 3-5% of bletilla extract, 0.5-1% of dendrobium extract and 0.5-1% of sodium lauryl sulfate, The balance of purified water;
further, the feed additive comprises the following raw materials in parts by weight: 0.05% of triclosan, 2% of herbal essence, 0.5% of scutellaria baicalensis, 0.08% of sophora flavescens, 0.03% of andrographis paniculata, 2% of vitamin C, 5% of lactoferrin, 10% of biological lysozyme, 2% of a. nepalensis extract, 1% of indocalamus leaf, 5% of a licorice extract, 2% of an isatis root extract, 2% of a forsythia suspense extract, 4% of sorbitol, 30% of hydrated silica, 4% of plant polypeptide, 0.3% of propolis, 2% of menthol, 0.5% of a honeysuckle extract, 9% of glycerol, 3% of a bletilla striata extract, 0.5% of a dendrobium officinale extract, 0.5% of;
further, the feed additive comprises the following raw materials in parts by weight: 0.3% of triclosan, 2% of herbal essence, 1% of scutellaria baicalensis, 0.1% of sophora flavescens, 0.05% of andrographis paniculata, 2% of vitamin C, 3% of lactoferrin, 12% of biological lysozyme, 3% of a. nepalensis extract, 2% of indocalamus leaves, 4% of a licorice extract, 4% of an isatis root extract, 1% of a fructus forsythiae extract, 7% of sorbitol, 32% of hydrated silica, 5% of plant polypeptide, 0.2% of propolis, 3% of menthol, 0.6% of a honeysuckle extract, 8% of glycerol, 4% of a bletilla striata extract, 0.7% of a dendrobium officinale extract, 0.8% of sodium;
further, the feed additive comprises the following raw materials in parts by weight: 0.2% of triclosan, 1.5% of herbal essence, 0.7% of scutellaria baicalensis, 0.07% of sophora flavescens, 0.03% of andrographis paniculata, 2.5% of vitamin C, 4% of lactoferrin, 13% of biological lysozyme, 3% of a. nepalensis extract, 1.5% of indocalamus leaves, 5% of a licorice extract, 3% of an isatis root extract, 1% of a forsythia suspense extract, 5% of sorbitol, 32% of hydrated silica, 6% of plant polypeptide, 0.4% of propolis, 3% of menthol, 0.7% of a honeysuckle extract, 9% of glycerol, 4% of a bletilla striata extract, 0.8% of a dendrobium officinale extract, 0.6% of;
further, the herbal essence adopts menthol.
After the scheme is adopted, the invention has the beneficial effects that: the oral care product for resisting helicobacter pylori, disclosed by the invention, can clean the oral cavity, whiten teeth and refresh breath, can effectively inhibit the breeding of bacteria in the oral cavity, and has the functions of resisting bacteria and infection.
Detailed Description
The present invention is further described below.
Example 1: an anti-helicobacter pylori oral care product comprises the following raw materials in parts by weight: 0.05% of triclosan, 2% of menthol, 0.5% of scutellaria baicalensis, 0.08% of sophora flavescens, 0.03% of andrographis paniculata, 2% of vitamin C, 5% of lactoferrin, 10% of biological lysozyme, 2% of a. nepalensis extract, 1% of indocalamus leaf, 5% of a licorice extract, 2% of an isatis root extract, 2% of a fructus forsythiae extract, 4% of sorbitol, 30% of hydrated silica, 4% of plant polypeptide, 0.3% of propolis, 2% of menthol, 0.5% of a honeysuckle extract, 9% of glycerol, 3% of a bletilla striata extract, 0.5% of a dendrobium officinale extract, 0.5% of sodium.
Example 2: an anti-helicobacter pylori oral care product comprises the following raw materials in parts by weight: 0.3% of triclosan, 2% of menthol, 1% of scutellaria baicalensis, 0.1% of sophora flavescens, 0.05% of andrographis paniculata, 2% of vitamin C, 3% of lactoferrin, 12% of biological lysozyme, 3% of a. nepalensis extract, 2% of indocalamus leaves, 4% of a licorice extract, 4% of an isatis root extract, 1% of a fructus forsythiae extract, 7% of sorbitol, 32% of hydrated silica, 5% of plant polypeptide, 0.2% of propolis, 3% of menthol, 0.6% of a honeysuckle extract, 8% of glycerol, 4% of a bletilla striata extract, 0.7% of a dendrobium officinale extract, 0.8% of sodium.
Example 3: an anti-helicobacter pylori oral care product comprises the following raw materials in parts by weight: 0.2% of triclosan, 1.5% of menthol, 0.7% of scutellaria baicalensis, 0.07% of sophora flavescens, 0.03% of andrographis paniculata, 2.5% of vitamin C, 4% of lactoferrin, 13% of biological lysozyme, 3% of a. nepalensis extract, 1.5% of indocalamus leaves, 5% of a licorice extract, 3% of an isatis root extract, 1% of a forsythia suspense extract, 5% of sorbitol, 32% of hydrated silica, 6% of a plant polypeptide, 0.4% of propolis, 3% of menthol, 0.7% of a honeysuckle extract, 9% of glycerol, 4% of a bletilla striata extract, 0.8% of a dendrobium officinale extract, 0.6%.
The using method of the invention is as follows: the tooth brushing is carried out at least twice a day, and the tooth brushing is needed to be used in the morning and evening or after a meal, or the tooth brushing liquid is smeared at the uncomfortable position of the oral cavity and is removed by gargling after a moment.
Experiments prove that: triclosan has antiinflammatory, antiallergic, vasoconstrictor, antiproliferative, antipruritic, and exudation preventing effects, and has good effect in inhibiting bacteria and fungi in oral cavity; the scutellaria baicalensis, the sophora flavescens and the andrographis paniculata are used in a matching way, the effects of clearing heat, removing toxicity, diminishing inflammation and sterilizing are more obvious, and the indocalamus leaf can clear heat, stop bleeding, remove toxicity, relieve swelling and effectively inhibit the breeding of bacteria in the oral cavity.
The above description is only for the purpose of illustrating the technical solutions of the present invention and not for the purpose of limiting the same, and other modifications or equivalent substitutions made by those skilled in the art to the technical solutions of the present invention should be covered within the scope of the claims of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (5)
1. An anti-helicobacter pylori oral care product is characterized by comprising the following raw materials in parts by weight: 0.05-0.3% of triclosan, 1-2% of herbal essence, 0.5-1% of scutellaria baicalensis, 0.05-0.1% of radix sophorae flavescentis, 0.02-0.05% of common andrographis herb, 2-3% of vitamin C, 2-5% of lactoferrin, 10-15% of biological lysozyme, 2-3% of Nipagin cinnamon extract, 1-2% of indocalamus leaf, 4-6% of liquorice extract, 2-4% of isatis root extract, 1-2% of fructus forsythiae extract, 3-8% of sorbitol, 30-35% of hydrated silica, 4-7% of plant polypeptide, 0.2-0.6% of propolis, 2-4% of menthol, 0.5-1% of honeysuckle extract, 8-10% of glycerol, 3-5% of bletilla extract, 0.5-1% of dendrobium extract and 0.5-1% of sodium lauryl sulfate, The balance being purified water.
2. The anti-helicobacter pylori oral care product according to claim 1, characterized in that the product comprises the following raw materials in parts by weight: 0.05% of triclosan, 2% of herbal essence, 0.5% of scutellaria baicalensis, 0.08% of sophora flavescens, 0.03% of andrographis paniculata, 2% of vitamin C, 5% of lactoferrin, 10% of biological lysozyme, 2% of a. nepalensis extract, 1% of indocalamus leaf, 5% of a licorice extract, 2% of an isatis root extract, 2% of a forsythia suspense extract, 4% of sorbitol, 30% of hydrated silica, 4% of plant polypeptide, 0.3% of propolis, 2% of menthol, 0.5% of a honeysuckle extract, 9% of glycerol, 3% of a bletilla striata extract, 0.5% of a dendrobium officinale extract, 0.5% of.
3. The anti-helicobacter pylori oral care product according to claim 1, characterized in that the product comprises the following raw materials in parts by weight: 0.3% of triclosan, 2% of herbal essence, 1% of scutellaria baicalensis, 0.1% of sophora flavescens, 0.05% of andrographis paniculata, 2% of vitamin C, 3% of lactoferrin, 12% of biological lysozyme, 3% of a. nepalensis extract, 2% of indocalamus leaves, 4% of a licorice extract, 4% of an isatis root extract, 1% of a fructus forsythiae extract, 7% of sorbitol, 32% of hydrated silica, 5% of plant polypeptide, 0.2% of propolis, 3% of menthol, 0.6% of a honeysuckle extract, 8% of glycerol, 4% of a bletilla striata extract, 0.7% of a dendrobium officinale extract, 0.8% of sodium.
4. The anti-helicobacter pylori oral care product according to claim 1, characterized in that the product comprises the following raw materials in parts by weight: 0.2% of triclosan, 1.5% of herbal essence, 0.7% of scutellaria baicalensis, 0.07% of sophora flavescens, 0.03% of andrographis paniculata, 2.5% of vitamin C, 4% of lactoferrin, 13% of biological lysozyme, 3% of a. nepalensis extract, 1.5% of indocalamus leaves, 5% of a licorice extract, 3% of an isatis root extract, 1% of a forsythia suspense extract, 5% of sorbitol, 32% of hydrated silica, 6% of plant polypeptide, 0.4% of propolis, 3% of menthol, 0.7% of a honeysuckle extract, 9% of glycerol, 4% of a bletilla striata extract, 0.8% of a dendrobium officinale extract, 0.6% of.
5. The anti-helicobacter pylori oral care product according to claim 1, 2, 3 or 4, wherein the herbal essence is menthol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110102308.7A CN112870144A (en) | 2021-01-25 | 2021-01-25 | Oral care product for resisting helicobacter pylori |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110102308.7A CN112870144A (en) | 2021-01-25 | 2021-01-25 | Oral care product for resisting helicobacter pylori |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112870144A true CN112870144A (en) | 2021-06-01 |
Family
ID=76053075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110102308.7A Pending CN112870144A (en) | 2021-01-25 | 2021-01-25 | Oral care product for resisting helicobacter pylori |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112870144A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113476556A (en) * | 2021-07-27 | 2021-10-08 | 天津济康药业有限公司 | Composition for inhibiting helicobacter pylori in oral cavity |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110522670A (en) * | 2019-09-21 | 2019-12-03 | 广州市可优美科技有限公司 | A kind of long-acting anti-helicobacter pylori toothpaste |
| CN111000752A (en) * | 2020-01-06 | 2020-04-14 | 陕西润和堂医药有限公司 | Traditional Chinese medicine toothpaste for resisting helicobacter pylori |
| CN111643393A (en) * | 2020-07-13 | 2020-09-11 | 幽汰(福建)大健康产业有限公司 | Oral toothpaste for inhibiting helicobacter pylori and preparation device thereof |
-
2021
- 2021-01-25 CN CN202110102308.7A patent/CN112870144A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110522670A (en) * | 2019-09-21 | 2019-12-03 | 广州市可优美科技有限公司 | A kind of long-acting anti-helicobacter pylori toothpaste |
| CN111000752A (en) * | 2020-01-06 | 2020-04-14 | 陕西润和堂医药有限公司 | Traditional Chinese medicine toothpaste for resisting helicobacter pylori |
| CN111643393A (en) * | 2020-07-13 | 2020-09-11 | 幽汰(福建)大健康产业有限公司 | Oral toothpaste for inhibiting helicobacter pylori and preparation device thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113476556A (en) * | 2021-07-27 | 2021-10-08 | 天津济康药业有限公司 | Composition for inhibiting helicobacter pylori in oral cavity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108785161B (en) | Antibacterial mouth wash containing licoflavone and preparation method thereof | |
| CN111000752A (en) | Traditional Chinese medicine toothpaste for resisting helicobacter pylori | |
| CN105232403A (en) | Anti-allergy toothpaste capable of achieving prevention and adjuvant treatment of stomach illness | |
| CN101357154A (en) | Chinese herbal medicine composition with bacteriostasis, anti-inflammation hemostasia effect | |
| Jain et al. | Propolis in oral health: a natural remedy | |
| CN112870144A (en) | Oral care product for resisting helicobacter pylori | |
| CN106511185A (en) | Toothpaste for preventing and treating gingival bleeding and preparation method thereof | |
| CN115624499A (en) | Whitening and antiallergic toothpaste | |
| CN112569154B (en) | Plant antibacterial oral care product | |
| WO2016010284A1 (en) | Toothpaste composition containing curcuma longa l., and preparation method therefor | |
| CN103445977A (en) | Calcium carbonate type toothpaste | |
| CN112972355A (en) | Traditional Chinese medicine toothpaste and preparation method thereof | |
| CN108478500B (en) | Composition for oral cavity and application thereof | |
| CN112716854B (en) | Traditional Chinese medicine toothpaste and preparation method thereof | |
| CN105456148A (en) | Chinese herbal medicine toothpaste and preparation method thereof | |
| CN103751284B (en) | The application of osmanthus essential oil in dental caries | |
| CN106344451A (en) | Traditional Chinese medicine tooth-care toothpaste | |
| CN111743838A (en) | Traditional Chinese medicine mouth wash and preparation method thereof | |
| CN112137928A (en) | Multi-effect toothpaste and preparation method thereof | |
| CN112438924A (en) | Traditional Chinese medicine mouth wash | |
| CN109745263B (en) | Compound traditional Chinese medicine toothpaste containing subprostrate sophora and pseudo-ginseng and preparation method thereof | |
| AU2021105236A4 (en) | Natural Herbal Mouthwash Containing Lycium Barbarum Leaves for Treating Gingivitis and Oral Ulcer and Preparation Method Thereof | |
| CN104434608A (en) | Traditional Chinese medicine gingival nursing toothpaste | |
| CN116196258A (en) | A toothpaste containing radix Isatidis and Scutellariae radix extract for clearing heat and purging pathogenic fire, and its preparation method | |
| CN108652998A (en) | A kind of nursing tooth liquid and preparation method thereof improving oral inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210601 |